Logo image of COHR

COHERENT CORP (COHR) Stock Fundamental Analysis

NYSE:COHR - New York Stock Exchange, Inc. - US19247G1076 - Common Stock - Currency: USD

82.64  -3.6 (-4.17%)

After market: 82 -0.64 (-0.77%)

Fundamental Rating

4

COHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. There are concerns on the financial health of COHR while its profitability can be described as average. COHR is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year COHR was profitable.
In the past year COHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: COHR reported negative net income in multiple years.
In the past 5 years COHR always reported a positive cash flow from operatings.
COHR Yearly Net Income VS EBIT VS OCF VS FCFCOHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

COHR has a Return On Assets (-0.42%) which is in line with its industry peers.
With a Return On Equity value of -0.78%, COHR perfoms like the industry average, outperforming 49.17% of the companies in the same industry.
COHR has a Return On Invested Capital of 2.99%. This is comparable to the rest of the industry: COHR outperforms 56.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for COHR is significantly below the industry average of 8.95%.
The 3 year average ROIC (2.57%) for COHR is below the current ROIC(2.99%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.42%
ROE -0.78%
ROIC 2.99%
ROA(3y)-0.92%
ROA(5y)-0.01%
ROE(3y)-1.83%
ROE(5y)-0.48%
ROIC(3y)2.57%
ROIC(5y)2.95%
COHR Yearly ROA, ROE, ROICCOHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

The Operating Margin of COHR (9.20%) is better than 79.17% of its industry peers.
In the last couple of years the Operating Margin of COHR has declined.
The Gross Margin of COHR (33.49%) is comparable to the rest of the industry.
COHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.2%
PM (TTM) N/A
GM 33.49%
OM growth 3Y-33.11%
OM growth 5Y-22.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.56%
GM growth 5Y-4.17%
COHR Yearly Profit, Operating, Gross MarginsCOHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COHR is destroying value.
COHR has more shares outstanding than it did 1 year ago.
COHR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, COHR has an improved debt to assets ratio.
COHR Yearly Shares OutstandingCOHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
COHR Yearly Total Debt VS Total AssetsCOHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

An Altman-Z score of 1.96 indicates that COHR is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.96, COHR is doing worse than 66.67% of the companies in the same industry.
The Debt to FCF ratio of COHR is 16.83, which is on the high side as it means it would take COHR, 16.83 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 16.83, COHR perfoms like the industry average, outperforming 48.33% of the companies in the same industry.
COHR has a Debt/Equity ratio of 0.50. This is a neutral value indicating COHR is somewhat dependend on debt financing.
COHR's Debt to Equity ratio of 0.50 is on the low side compared to the rest of the industry. COHR is outperformed by 74.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.83
Altman-Z 1.96
ROIC/WACC0.34
WACC8.76%
COHR Yearly LT Debt VS Equity VS FCFCOHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.67 indicates that COHR has no problem at all paying its short term obligations.
COHR has a Current ratio (2.67) which is comparable to the rest of the industry.
COHR has a Quick Ratio of 1.64. This is a normal value and indicates that COHR is financially healthy and should not expect problems in meeting its short term obligations.
COHR's Quick ratio of 1.64 is in line compared to the rest of the industry. COHR outperforms 45.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 1.64
COHR Yearly Current Assets VS Current LiabilitesCOHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.42% over the past year.
The Earnings Per Share has been decreasing by -8.30% on average over the past years.
COHR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.60%.
The Revenue has been growing by 28.14% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)87.42%
EPS 3Y-23.51%
EPS 5Y-8.3%
EPS Q2Q%163.89%
Revenue 1Y (TTM)14.6%
Revenue growth 3Y14.87%
Revenue growth 5Y28.14%
Sales Q2Q%26.8%

3.2 Future

Based on estimates for the next years, COHR will show a very strong growth in Earnings Per Share. The EPS will grow by 48.77% on average per year.
Based on estimates for the next years, COHR will show a quite strong growth in Revenue. The Revenue will grow by 13.04% on average per year.
EPS Next Y112.78%
EPS Next 2Y64.54%
EPS Next 3Y48.77%
EPS Next 5YN/A
Revenue Next Year19.15%
Revenue Next 2Y15.17%
Revenue Next 3Y13.04%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
COHR Yearly Revenue VS EstimatesCOHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
COHR Yearly EPS VS EstimatesCOHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.20 indicates a quite expensive valuation of COHR.
COHR's Price/Earnings ratio is a bit cheaper when compared to the industry. COHR is cheaper than 60.83% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.63. COHR is around the same levels.
With a Price/Forward Earnings ratio of 18.39, COHR is valued on the expensive side.
Based on the Price/Forward Earnings ratio, COHR is valued a bit cheaper than the industry average as 72.50% of the companies are valued more expensively.
COHR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 29.2
Fwd PE 18.39
COHR Price Earnings VS Forward Price EarningsCOHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

COHR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. COHR is cheaper than 65.00% of the companies in the same industry.
COHR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 55.85
EV/EBITDA 15.62
COHR Per share dataCOHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

COHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COHR's earnings are expected to grow with 48.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y64.54%
EPS Next 3Y48.77%

More info and screens

0

5. Dividend

5.1 Amount

COHR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COHERENT CORP

NYSE:COHR (2/21/2025, 8:10:32 PM)

After market: 82 -0.64 (-0.77%)

82.64

-3.6 (-4.17%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners88.67%
Inst Owner Change-0.51%
Ins Owners0.58%
Ins Owner Change6.78%
Market Cap12.81B
Analysts79.26
Price Target115.89 (40.23%)
Short Float %3.55%
Short Ratio1.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.22%
Min EPS beat(2)18.17%
Max EPS beat(2)34.28%
EPS beat(4)4
Avg EPS beat(4)19.01%
Min EPS beat(4)0.45%
Max EPS beat(4)34.28%
EPS beat(8)7
Avg EPS beat(8)14.95%
EPS beat(12)11
Avg EPS beat(12)12.77%
EPS beat(16)15
Avg EPS beat(16)10.96%
Revenue beat(2)2
Avg Revenue beat(2)1.43%
Min Revenue beat(2)0.53%
Max Revenue beat(2)2.33%
Revenue beat(4)4
Avg Revenue beat(4)1.34%
Min Revenue beat(4)0.53%
Max Revenue beat(4)2.33%
Revenue beat(8)5
Avg Revenue beat(8)-0.47%
Revenue beat(12)7
Avg Revenue beat(12)-0.49%
Revenue beat(16)8
Avg Revenue beat(16)-0.76%
PT rev (1m)1.42%
PT rev (3m)23.23%
EPS NQ rev (1m)12.02%
EPS NQ rev (3m)14.68%
EPS NY rev (1m)14.42%
EPS NY rev (3m)14.5%
Revenue NQ rev (1m)2.65%
Revenue NQ rev (3m)6.68%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 29.2
Fwd PE 18.39
P/S 2.41
P/FCF 55.85
P/OCF 20.65
P/B 1.69
P/tB N/A
EV/EBITDA 15.62
EPS(TTM)2.83
EY3.42%
EPS(NY)4.49
Fwd EY5.44%
FCF(TTM)1.48
FCFY1.79%
OCF(TTM)4
OCFY4.84%
SpS34.24
BVpS49.02
TBVpS-0.69
PEG (NY)0.26
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.42%
ROE -0.78%
ROCE 3.79%
ROIC 2.99%
ROICexc 3.22%
ROICexgc 9.04%
OM 9.2%
PM (TTM) N/A
GM 33.49%
FCFM 4.32%
ROA(3y)-0.92%
ROA(5y)-0.01%
ROE(3y)-1.83%
ROE(5y)-0.48%
ROIC(3y)2.57%
ROIC(5y)2.95%
ROICexc(3y)3.83%
ROICexc(5y)4.17%
ROICexgc(3y)8.28%
ROICexgc(5y)8.58%
ROCE(3y)3.26%
ROCE(5y)3.73%
ROICexcg growth 3Y-38.53%
ROICexcg growth 5Y-25%
ROICexc growth 3Y-46.21%
ROICexc growth 5Y-34.59%
OM growth 3Y-33.11%
OM growth 5Y-22.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.56%
GM growth 5Y-4.17%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 16.83
Debt/EBITDA 3.67
Cap/Depr 70.34%
Cap/Sales 7.37%
Interest Coverage 1.65
Cash Conversion 59.41%
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 1.64
Altman-Z 1.96
F-Score6
WACC8.76%
ROIC/WACC0.34
Cap/Depr(3y)78.52%
Cap/Depr(5y)70.67%
Cap/Sales(3y)8.43%
Cap/Sales(5y)7.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.42%
EPS 3Y-23.51%
EPS 5Y-8.3%
EPS Q2Q%163.89%
EPS Next Y112.78%
EPS Next 2Y64.54%
EPS Next 3Y48.77%
EPS Next 5YN/A
Revenue 1Y (TTM)14.6%
Revenue growth 3Y14.87%
Revenue growth 5Y28.14%
Sales Q2Q%26.8%
Revenue Next Year19.15%
Revenue Next 2Y15.17%
Revenue Next 3Y13.04%
Revenue Next 5YN/A
EBIT growth 1Y154.68%
EBIT growth 3Y-23.16%
EBIT growth 5Y-0.2%
EBIT Next Year84.01%
EBIT Next 3Y34.79%
EBIT Next 5YN/A
FCF growth 1Y1449.34%
FCF growth 3Y-22.55%
FCF growth 5Y36.88%
OCF growth 1Y31.02%
OCF growth 3Y-1.69%
OCF growth 5Y25.05%